Junko Sato

Determinants of the Quality of Life in Alzheimer’s Disease Patients as Assessed by the Japanese Version of the Quality of Life – Alzheimer’s Disease Scale

Teruo Matsui, Shutaro Nakaaki, Yoshie Murata et al. · Dementia and Geriatric Cognitive Disorders · 2006 · 99 citations

Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: A two‐year follow‐up study

Hiroshi Tatsumi, Shutaro Nakaaki, Katsuyoshi Torii et al. · Psychiatry and Clinical Neurosciences · 2009 · 92 citations

Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens’ antibacterial susceptibility

Akira Watanabe, Katsunori Yanagihara, Tetsuya Matsumoto et al. · Journal of Infection and Chemotherapy · 2012 · 75 citations · Full text

Antibiotics, Surveillance Committee, Medicine +11

Same Drug, Different Dosing: Differences in Dosing for Drugs Approved in the United States, Europe, and Japan

Henry Malinowski, Agnes Westelinck, Junko Sato et al. · The Journal of Clinical Pharmacology · 2008 · 74 citations

Drug Policy, Pharmacotherapy, Off-label Drug Use +16

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus

Hiroshi Hayami, Satoshi Takahashi, Kiyohito Ishikawa et al. · Journal of Infection and Chemotherapy · 2013 · 64 citations · Full text

Antibiotics, Medicine, Healthcare-associated Infection +9